Saturday, April 12 | 2–2:20 p.m.
Rami Mahfouz, M.D., American University of Beirut Medical Center
Description to come.
Soufiane El Hallani, M.D., University of Alberta
Description to come.
Abdullah Alsuwaidan, M.D., King Faisal Specialist Hospital and Research Centre
Cell-free circulating tumor DNA (cf-tDNA) has transformed the practice of precision medicine in oncology. The talk will explore how advancements in ultra-sensitive sequencing technologies and optimized pre-analytical workflows enable the detection and analysis of cf-tDNA, even at low concentrations. The session will highlight the role of unique molecular identifiers (UMIs) in reducing sequencing errors, discuss the critical implications of molecular heterogeneity, and examine the applications of liquid biopsy in monitoring minimal residual disease (MRD), guiding treatment decisions, and detecting resistance mechanisms in real-time.
The program includes sessions, networking opportunities, industry spotlights and more.
View program
